During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

The findings show that prolonged targeted therapy in patients with head and neck cancer can heighten tumor alertness, ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Dr. Kellie Smith discusses T-cell immunology, lung cancer immunotherapy, MANASCORE, multi-omics research, and navigating today's scientific climate.

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...

Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® Lung Cancer Summit. For patients with advanced-stage non-small cell lung ...

A pair of immunotherapy drugs have shown impressive results in treating a subset of colorectal cancer known as mismatch repair-deficient (dMMR) colorectal cancer. DMMR colorectal cancer is ...

A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments SEATTLE — July 23, 2025 — A landmark study has ...

Researchers conducted a systematic review of studies assessing the cost-effectiveness or cost-utility of adjuvant immunotherapy for treating various types of cancer.

Please provide your email address to receive an email when new articles are posted on . High-cost immunotherapy was associated with increased likelihood of being unable to afford medical care and ...